Caracterización de la estadificación molecular en carcinoma de colon. Correlación clínico-histológica

Caracterización de la estadificación molecular
en carcinoma de colon. Correlación clínico-histológica
Iban Aldecoa Ansórregui
Aquesta tesi doctoral està subjecta a la llicència Reconeixement 3.0. Espanya de Creative
Commons.
Esta tesis doctoral está sujeta a la licencia Reconocimiento 3.0. España de Creative
Commons.
This doctoral thesis is licensed under the Creative Commons Attribution 3.0. Spain License.

P á g i n a | 117
Tesis Doctoral |Iban Aldecoa Ansorregui
BIBLIOGRAFÍA

P á g i n a | 118
Tesis Doctoral |Iban Aldecoa Ansorregui

P á g i n a | 119
Tesis Doctoral |Iban Aldecoa Ansorregui
1. Singh-Ranger, G. The American Joint
Committee on Cancer staging (AJCC) Atlas,
by Greene FL, Compton CC, Fritz AG, Shah
JP, Winchester DP. Int. Semin. Surg. Oncol. 3,
34 (2006).
2. Stewart, S. L., Wike, J. M., Kato, I., Lewis, D.
R. & Michaud, F. A population-based study of
colorectal cancer histology in the United
States, 1998–2001. Cancer 107, 1128–1141
(2006).
3. Tang, L. H. et al. Protocol for the Examination of
Specimens from Patients With Primary Carcinoma of
the Colon and Rectum. College of American
Pathologists. (2016).
4. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer
statistics, 2016. CA. Cancer J. Clin. 66, 7–30
(2016).
5. Quintero, E. et al. Colonoscopy versus Fecal
Immunochemical Testing in Colorectal-
Cancer Screening. N. Engl. J. Med. 366, 697–
706 (2012).
6. AECC. Incidencia del cáncer de colon.
Asociación Española contra el Cáncer (2016).
Available at:
https://www.aecc.es/SobreElCancer/Cancer
PorLocalizacion/cancerdecolon/Paginas/inci
dencia.aspx. (Accessed: 12th October 2016)
7. Ferlay, J. et al. Las Cifras del Cáncer en
España 2014. Soc. Española Oncol. Médica
(2014).
8. Castells, A., Castellví-Bel, S. & Balaguer, F.
Concepts in familial colorectal cancer: where
do we stand and what is the future?
Gastroenterology 137, 404–9 (2009).
9. Sobin LH, Gospodarowicz MK, W. C. UICC:
TNM Classification of Malignant Tumours. (Wiley-
Blackwell, 2009).
10. Trejo, D. S. El cribado del cáncer de colon en
España : Situación 2006-2014. Red de
Programas de Cribado de Cáncer (2014).
11. AECC. Programa de cribado de cáncer de
colon implantado al 100% en el País Vasco.
Vitoria-Gasteiz Available at:
https://www.aecc.es/Comunicacion/Noticias
/Paginas/Programadecribadodecolonimplanta
doal100enelPaisVasco.aspx.
12. Levin, B. et al. Screening and Surveillance for
the Early Detection of Colorectal Cancer and
Adenomatous Polyps, 2008: A Joint Guideline
from the American Cancer Society, the US
Multi-Society Task Force on Colorectal
Cancer, and the American College of
Radiology. CA. Cancer J. Clin. 58, 130–160
(2008).
13. Silvia, C. et al. Barreras en la implantación del
cribado del cáncer de colon en España. (Alianza para
la Prevención del Cáncer de Colon en España.
Madrid, 2011, 2011).
14. Wolff, W. I. Colonoscopy: history and
development. Am. J. Gastroenterol. 84, 1017–25
(1989).
15. Washington, M. K. et al. Protocol for the
examination of specimens from patients with
primary carcinoma of the colon and rectum.
Arch. Pathol. Lab. Med. 133, 1539–1551 (2009).
16. Williams, J. G. et al. Management of the
malignant colorectal polyp: ACPGBI position
statement. Color. Dis. 15, 1–38 (2013).
17. Bertelson, N. L. et al. Colectomy for
Endoscopically Unresectable Polyps. Dis.
Colon Rectum 55, 1111–1116 (2012).
18. Bujanda, L., Cosme, A., Gil, I. & Arenas-
Mirave, J. I. Malignant colorectal polyps.
World J. Gastroenterol. 16, 3103–3111 (2010).
19. Ellis, K. K. & Fennerty, M. B. Marking and
identifying colon lesions. Tattoos, clips, and
radiology in imaging the colon. Gastrointest.
Endosc. Clin. N. Am. 7, 401–11 (1997).
20. Sauntry, J. P. & Knudtson, K. P. A technique
for marking the mucosa of the gastrointestinal
tract after polypectomy. Cancer 11, 607–10
21. Knoernschild, H. E. The use of a tattooing
instrument for marking colonic mucosa. Am.
J. Surg. 103, 83–5 (1962).
22. Ponsky, J. L. & King, J. F. Endoscopic
marking of colonic lesions. Gastrointest. Endosc.
22, 42–3 (1975).
23. Hammond, D. C. et al. Endoscopic tattooing
of the colon. An experimental study. Am. Surg.
55, 457–61 (1989).
24. Askin, M. P., Waye, J. D., Fiedler, L. &
Harpaz, N. Tattoo of colonic neoplasms in
113 patients with a new sterile carbon
compound. Gastrointest. Endosc. 56, 339–42
(2002).
25. Nizam, R., Siddiqi, N., Landas, S. K., Kaplan,
D. S. & Holtzapple, P. G. Colonic tattooing
with India ink: benefits, risks, and alternatives.
Am. J. Gastroenterol. 91, 1804–8 (1996).
26. Kethu, S. R. et al. Endoscopic tattooing.
Gastrointest. Endosc. 72, 681–5 (2010).
27. Trakarnsanga, A. Endoscopic tattooing of
colorectal lesions: Is it a risk-free procedure?
World J. Gastrointest. Endosc. 3, 256 (2011).
28. Salomon, P., Berner, J. S. & Waye, J. D.
Endoscopic India ink injection: a method for
preparation, sterilization, and administration.
Gastrointest. Endosc. 39, 803–5
29. Ginsberg, G. G. et al. The argon plasma
coagulator: February 2002. Gastrointest. Endosc.
55, 807–10 (2002).
30. Botoman, V. A., Pietro, M. & Thirlby, R. C.

P á g i n a | 120
Tesis Doctoral |Iban Aldecoa Ansorregui
Localization of colonic lesions with
endoscopic tattoo. Dis. Colon Rectum 37, 775–6
(1994).
31. Hornig, D., Kühn, H., Stadelmann, O. &
Bötticher, R. Phlegmonous gastritis after
Indian ink marking. Endoscopy 15, 266–9
(1983).
32. Coman, E. et al. Fat necrosis and
inflammatory pseudotumor due to endoscopic
tattooing of the colon with india ink.
Gastrointest. Endosc. 37, 65–8
33. Dell’Abate, P. et al. Endoscopic preoperative
colonic tattooing: a clinical and surgical
complication. Endoscopy 31, 271–3 (1999).
34. Park, S. I., Genta, R. S., Romeo, D. P. &
Weesner, R. E. Colonic abscess and focal
peritonitis secondary to india ink tattooing of
the colon. Gastrointest. Endosc. 37, 68–71
35. McArthur, C. S., Roayaie, S. & Waye, J. D.
Safety of preoperation endoscopic tattoo with
india ink for identification of colonic lesions.
Surg. Endosc. 13, 397–400 (1999).
36. Cahill, R. A., Lindsey, I. & Cunningham, C.
Sentinel node mapping by colonic tattooing.
Surg. Endosc. 24, 2365–6 (2010).
37. Dawson, K., Wiebusch, A. & Thirlby, R. C.
Preoperative tattooing and improved lymph
node retrieval rates from colectomy
specimens in patients with colorectal cancers.
Arch. Surg. 145, 826–830 (2010).
38. Bartels, S. A. L., van der Zaag, E. S., Dekker,
E., Buskens, C. J. & Bemelman, W. A. The
effect of colonoscopic tattooing on lymph
node retrieval and sentinel lymph node
mapping. Gastrointest. Endosc. 76, 793–800
(2012).
39. Kang, J. et al. Effect of preoperative
colonoscopic tattooing on lymph node
harvest in T1 colorectal cancer. Int. J. Colorectal
Dis. 30, 1349–1355 (2015).
40. Feo, C. V et al. Preoperative endoscopic
tattooing to mark the tumour site does not
improve lymph node retrieval in colorectal
cancer: a retrospective cohort study. J. Negat.
Results Biomed. 14, 9 (2015).
41. Spatz, H. et al. Sentinel lymph node mapping
as a side-effect of colonoscopic tattooing.
Surg. Endosc. 24, 589–93 (2009).
42. Viehl, C. T. et al. Carbon dye staining of
sentinel lymph nodes facilitates microstaging
of colon cancer patients. World J. Surg. 30,
453–456 (2006).
43. Dunaway, M. T., Webb, W. R. & Rodning, C.
B. Intraluminal measurement of distance in
the colorectal region employing rigid and
flexible endoscopes. Surg. Endosc. 2, 81–3
(1988).
44. Frager, D. H., Frager, J. D., Wolf, E. L. &
Beneventano, T. C. Problems in the
colonoscopic localization of tumors:
continued value of the barium enema.
Gastrointest. Radiol. 12, 343–6 (1987).
45. Cho, Y. B. et al. Tumor localization for
laparoscopic colorectal surgery. World J. Surg.
31, 1491–1495 (2007).
46. Poulard, J. B., Shatz, B. & Kodner, I.
Preoperative tattooing of polypectomy site.
Endoscopy 17, 84–5 (1985).
47. Zmora, O. et al. Intraoperative endoscopy in
laparoscopic colectomy. Surg. Endosc. 16, 808–
11 (2002).
48. Montorsi, M. et al. Original technique for
small colorectal tumor localization during
laparoscopic surgery. Dis. Colon Rectum 42,
819–22 (1999).
49. Desch, C. E. et al. Colorectal cancer
surveillance: 2005 update of an American
Society of Clinical Oncology practice
guideline. J. Clin. Oncol. 23, 8512–9 (2005).
50. Meyerhardt, J. A. et al. Follow-up care,
surveillance protocol, and secondary
prevention measures for survivors of
colorectal cancer: American society of clinical
oncology clinical practice guideline
endorsement. J. Clin. Oncol. 31, 4465–4470
(2013).
51. Hammarström, S. The carcinoembryonic
antigen (CEA) family: structures, suggested
functions and expression in normal and
malignant tissues. Semin. Cancer Biol. 9, 67–81
(1999).
52. Nicholson, B. D. et al. Blood Measurement of
Carcinoembryonic Antigen Level for
Detecting Recurrence of Colorectal Cancer.
JAMA 316, 1310 (2016).
53. Gold, B., Cankovic, M., Furtado, L. V., Meier,
F. & Gocke, C. D. Do circulating tumor cells,
exosomes, and circulating tumor nucleic acids
have clinical utility?: A report of the
association for molecular pathology. J. Mol.
Diagnostics 17, 209–224 (2015).
54. Pohl, M. & Schmiegel, W. Therapeutic
Strategies in Diseases of the Digestive Tract -
2015 and beyond Targeted Therapies in Colon
Cancer Today and Tomorrow. Dig. Dis. 34,
574–579 (2016).
55. Ignatiadis, M., Lee, M. & Jeffrey, S. S.
Circulating tumor cells and circulating tumor
DNA: Challenges and opportunities on the
path to clinical utility. Clin. Cancer Res. 21,
4786–4800 (2015).
56. Abdallah, E. A. et al. Thymidylate synthase